<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03326323</url>
  </required_header>
  <id_info>
    <org_study_id>172809</org_study_id>
    <nct_id>NCT03326323</nct_id>
  </id_info>
  <brief_title>Biomarker and Thrombogenicity Assessment in Cardiopulmonary Bypass Surgery Utilizing Acute Normovolemic Hemodilution</brief_title>
  <acronym>TARGET-ANH</acronym>
  <official_title>A Pilot Study Involving the Changes in the Markers of Coagulation During Cardiopulmonary Bypass Surgery Utilizing Acute Normovolemic Hemodilution</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inova Health Care Services</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instrumentation Laboratory</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Inova Health Care Services</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will help enhance current understanding of the impact of Acute Normovolemic
      Hemodilution (ANH) administration on transfusion requirements post cardiac surgery, the
      effect of this procedure on coagulation, and platelet hemostasis, and the amount of chest
      tube drainage 24 hours post coronary artery bypass graft surgery (CABG) surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute Normovolemic Hemodilution (ANH) involves the removal of the patients own blood
      immediately at the induction of anesthesia and replacement of this blood intraoperatively
      with an equivalent volume of crystalloid or colloid solution in order to dissuade the loss of
      red blood cell mass, the mechanism of action is dilution of the blood, hematocrit reduction,
      and reduction of the anticoagulant components of the blood associated with bleeding during
      cardiopulmonary bypass graft surgery. The collected blood is isolated from the negative
      effects of the cardiopulmonary bypass machine.. The collected blood is then stored in
      anticoagulant treated blood bags in the cardiovascular operating room and re-infused into the
      patient in reverse order of collection at the commencement of surgery, leaving the most cell
      rich blood to be re-infused into the patient last. This study will evaluate the effect in
      patients with and without ANH utilization on; hemostatic markers, chest tube drainage 24
      hours post CABG, and need for allergenic blood transfusion. Positive effects on the
      hemostatic markers of anticoagulation and platelets, reduced chest tube drainage at 24 hours
      post CABG, and reduced number of transfused red blood cells will indicate a positive
      correlation with ANH utilization during isolated on pump CABG surgery.

      The benefits of ANH utilization in blood conservation will benefit patients by reducing their
      exposure to allogenic blood transfusion with its myriad side effects.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 19, 2018</start_date>
  <completion_date type="Actual">October 17, 2019</completion_date>
  <primary_completion_date type="Actual">September 17, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Recovery in Platelet Function Post ANH</measure>
    <time_frame>Baseline through 24 hours post ANH procedure</time_frame>
    <description>Time it takes (hours) for platelet function to recover post-ANH to pre-procedure levels as measured by platelet aggregation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recovery in Mean Clot Firmness Post ANH</measure>
    <time_frame>Baseline through 24 hours post ANH procedure</time_frame>
    <description>Time it takes for Mean Clot Firmness (MCF) to return normal levels post-ANH as measured by ROTEM</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">43</enrollment>
  <condition>Bleeding Reduction</condition>
  <arm_group>
    <arm_group_label>Patients undergoing ANH during CABG</arm_group_label>
    <description>Patients undergoing Acute Normovolemic Hemodilution during CABG surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Acute Normovolemic Hemodilution</intervention_name>
    <description>Collection and reinfusion of a patients own blood during coronary artery bypass graft surgery.</description>
    <arm_group_label>Patients undergoing ANH during CABG</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study population is inclusive of both genders and all racial and ethnic groups and
        subgroups. Subjects will be enrolled from age 18-85 years old.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. . Subject is 18-85 years old.

          2. . Subject is hemodynamically stable

          3. . The subject is able to read and has signed and dated the informed consent document
             including Health Insurance Portability and Accountability Act of 1996 (HIPAA)
             authorization permitting release of personal health information as approved by the
             investigator's Institutional Review Board (IRB).

        Exclusion Criteria:

          1. . Hematocrit &lt;30 at baseline

          2. . Insufficient (Low) on pump hematocrit of &lt; 21%

          3. . Patient is hemodynamically unstable

          4. . Patient requiring an emergency procedure

          5. . Left main coronary artery stenosis with evidence of hemodynamic instability (e.g..
             hypotension, ST segment elevations on electrocardiogram)

          6. . Aortic valve stenosis with evidence of hemodynamic instability (e.g.. hypotension,
             ST segment elevations on electrocardiogram)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric L Sarin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inova Heart and Vascular Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Inova Heart and Vascular Institute</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>October 26, 2017</study_first_submitted>
  <study_first_submitted_qc>October 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2017</study_first_posted>
  <results_first_submitted>December 6, 2019</results_first_submitted>
  <results_first_submitted_qc>December 31, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">January 13, 2020</results_first_posted>
  <last_update_submitted>December 31, 2019</last_update_submitted>
  <last_update_submitted_qc>December 31, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>acute normovolemic hemodilution</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 12, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/23/NCT03326323/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Patients Undergoing ANH During CABG</title>
          <description>Patients undergoing Acute Normovolemic Hemodilution during CABG surgery.
Acute Normovolemic Hemodilution: Collection and reinfusion of a patients own blood during coronary artery bypass graft surgery.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Unable to receive ANH protocol</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Patients Undergoing ANH During CABG</title>
          <description>Patients undergoing Acute Normovolemic Hemodilution during CABG surgery.
Acute Normovolemic Hemodilution: Collection and reinfusion of a patients own blood during coronary artery bypass graft surgery.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="43"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Recovery in Platelet Function Post ANH</title>
        <description>Time it takes (hours) for platelet function to recover post-ANH to pre-procedure levels as measured by platelet aggregation.</description>
        <time_frame>Baseline through 24 hours post ANH procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Patients Undergoing ANH During CABG</title>
            <description>Patients undergoing Acute Normovolemic Hemodilution during CABG surgery.
Acute Normovolemic Hemodilution: Collection and reinfusion of a patients own blood during coronary artery bypass graft surgery.</description>
          </group>
        </group_list>
        <measure>
          <title>Recovery in Platelet Function Post ANH</title>
          <description>Time it takes (hours) for platelet function to recover post-ANH to pre-procedure levels as measured by platelet aggregation.</description>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" spread="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Recovery in Mean Clot Firmness Post ANH</title>
        <description>Time it takes for Mean Clot Firmness (MCF) to return normal levels post-ANH as measured by ROTEM</description>
        <time_frame>Baseline through 24 hours post ANH procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Patients Undergoing ANH During CABG</title>
            <description>Patients undergoing Acute Normovolemic Hemodilution during CABG surgery.
Acute Normovolemic Hemodilution: Collection and reinfusion of a patients own blood during coronary artery bypass graft surgery.</description>
          </group>
        </group_list>
        <measure>
          <title>Recovery in Mean Clot Firmness Post ANH</title>
          <description>Time it takes for Mean Clot Firmness (MCF) to return normal levels post-ANH as measured by ROTEM</description>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>in-hospital and 30 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Patients Undergoing ANH During CABG</title>
          <description>Patients undergoing Acute Normovolemic Hemodilution during CABG surgery.
Acute Normovolemic Hemodilution: Collection and reinfusion of a patients own blood during coronary artery bypass graft surgery.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Eric L. Sarin MD</name_or_title>
      <organization>Inova Heart and Vascular Institute</organization>
      <phone>703-776-4138</phone>
      <email>eric.sarin@inova.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

